article thumbnail

Boehringer backs AI-powered anti-infective startup ArrePath

pharmaphorum

The Princeton, New Jersey-based startup will use the funding to develop its artificial intelligence and imaging based drug discovery platform, used to identify compounds with new and under-exploited mechanisms of action. million deaths a year, according to the 2019 Gram Report. Dr Zemer Gitai.

article thumbnail

ACMT Toxicology Visual Pearl: Who Doesn’t Like a Nice Rosé?

ALiEM - Pharm Pearls

 Deferoxamine binds with ferric iron (Fe3+) to form ferrioxamine, a water-soluble compound excreted in the urine. As Intensive Care Med 2014; 40(1):104. PMID Iron toxicity treated with deferoxamine Background Deferoxamine is the treatment for severe iron toxicity [1]. Deferoxamine Treasure Island (FL): StatPearls Publishing; 2023 Jan–.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Company profile: NeoImmuneTech

pharmaphorum

By enabling strong CD8 T-cell infiltration in cold tumor tissues, NT-I7, a compound developed by NeoImmuneTech, is capable of promoting a microenvironment that contributes to clinical efficacy, when combined with a CPI. Dr Se Hwan Yang, PhD, President and Chief Executive Officer, founded NeoImmuneTech in January 2014. Creation: Jan.

article thumbnail

GSK cancer head Hoos exits, takes top role at biotech Scorpion

pharmaphorum

Hoos is leaving GSK after nine years, a period that saw a complete revamp of the unit including the wholesale divestment of cancer drugs to Novartis in a $16 billion deal announced in 2014 – which completed as he took over the division.

article thumbnail

From Healing to Harm: The Unintended Consequences of Polypharmacy in Seniors

PharmD Live

The side effects can compound, resulting in a greater negative impact on a patient’s health than the individual effects of one medication alone. US Emergency Department Visits for Outpatient Adverse Drug Events, 2013-2014. Adverse Drug Reactions (ADRs) Adverse drug reactions are a major concern in polypharmacy. Campbell, N.

article thumbnail

Episode 864: Why Did ISMP Remove the Do Not Crush List from Their Website?

Pharmacy Joe

The removal appears to be in response to the publication of a 2021 article in the International Journal of Pharmaceutical Compounding. The list was originally compiled and updated by John Mitchell, PharmD, who passed away on June 10, 2014.

Dosage 111
article thumbnail

Extemporaneous Preparation with Unknown Stability

RX Note

Today, stability information can be obtained from manufacturer’s labelling information (such as in the package insert), the USP compounding monographs, or peer-reviewed articles and references , such as articles in American Journal of Health-System Pharmacy, the International Journal of Pharmaceutical Compounding.